ICOS and neoplasm: Our flow cytometric analysis showed differential expression of IL7R, CD40L, PD1, ICOS and HLA-DR between tumor Tfh-like subsets defined based on CD49f and CD103 expression within the CD4+ gate (Extended Data Fig. 3H).